B dot Medical
Latest round
- Series B
Last raised
- Mar 2023
Total raised
- $14M
Investors
- 8
About B dot Medical
, formerly part of the National Institute of Radiological Sciences, operates as a manufacturer and supplier of proton beam cancer treatment devices. In 2019, the company obtained its Medical Device Manufacturing Registration business license, and in 2020, it obtained a business license for first-class medical device manufacturing and sales business. The company's main businesses include the manufacture and sale of proton beam cancer treatment equipment, as well as research, development, and provision of particle beam cancer treatment.
Who invested in B dot Medical
8 investors across 4 rounds
See all investors in B dot Medical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about B dot Medical
Who invested in B dot Medical?
B dot Medical has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has B dot Medical raised?
B dot Medical has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did B dot Medical last raise money?
B dot Medical's most recent round on record is a Series B, in Mar 2023.
What does B dot Medical do?
, formerly part of the National Institute of Radiological Sciences, operates as a manufacturer and supplier of proton beam cancer treatment devices.
Where is B dot Medical headquartered?
B dot Medical is headquartered in Tokyo, Japan.
Which VCs invest in companies like B dot Medical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at B dot Medical's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like B dot Medical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.